
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+2
BioCheetah is a Singapore-based, Agency Science Technology and Research(A*STAR)-Institute of Molecular and Cell Biology(IMCB) spin-off company. It is primarily set up to develop and commercialize non-invasive, protein-based immunodiagnostic applications. First diagnostic applications in development are based on the proprietary bladder cancer biomarkers and detection antibodies discovered and developed in IMCB by BioCheetahs Scientific Founder (Prof. Jean-Paul Thiery) and the co-Founder/Chief Executive Officer (Dr. Kian-Chung Lee). Products to be developed include professional use in-vitro diagnostic ELISA and Point-of-care test (POCT) kits. The kits will employ a novel multiplex urine-based biomarkers panel with high sensitivity and specificity for diagnosis and monitoring of...
In-vitro diagnostics,rapid test,bladder cancer,urological cancers,poct,point-of-care test,and elisa
Biocheetah pte ltd operates in the Biotechnology research industry.
Biocheetah pte ltd's revenue is 11m - 100m
Biocheetah pte ltd has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.